Skip to content

Efficacy of essential oil mouthwash in reducing antimicrobial load among head and neck cancer treated patients post-radiotherapy - A clinical trial

ââ?¬Å?Antimicrobial efficacy of essential oils and their combination on microorganisms associated with post-radiation therapy in head and neck cancer patients: A double blind randomized controlled trialââ?¬?

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/08/044969
Enrollment
60
Registered
2022-08-26
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C068- Malignant neoplasm of overlappingsites of other and unspecified parts of mouth Health Condition 2: K137- Other and unspecified lesions of oral mucosa

Interventions

Intervention1: Freshly prepared mouthwash containing Cinnamon and Cajeput essential oils.: To be used as a mouthwash 10ml twice daily, morning and night, 30 minutes after brushing, swish for a full 30

Sponsors

Dr Mehul Ajit Shah
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients having histopathologically confirmed squamous cell carcinoma of head and neck region scheduled for 6ââ?¬â??7 weeks of RT with 60ââ?¬â??70Gy radiation dose (200cGy/ fraction for 5 days/week) irrespective of age and gender. 2.Patients with Karnofsky performance status score ââ?°Â¥70% (to assess the ability of the patients to follow instructions).

Exclusion criteria

Exclusion criteria: 1. Physically handicapped/terminally ill patients which can affect the use of mouthwash. 2. Patients using any other mouthwash.

Design outcomes

Primary

MeasureTime frame
Reduction in microbial load which may cause life-threatening opportunistic infections, leading to poor prognosis post-radiotherapy; and thereby providing an improved quality of life in patients treated with head and neck cancer patients.Timepoint: Baseline, 7th day and 28th day.

Secondary

MeasureTime frame
Preventing the progression of oral mucositis.Timepoint: Baseline, 7th day and 28th day

Countries

India

Contacts

Public ContactDr Anil V Ankola

KAHERs KLE Vishwanath Katti Institute of Dental Sciences

mehulshah1126@gmail.com07259480124

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026